272 related articles for article (PubMed ID: 10769285)
21. Propofol improves cardiac functional recovery after ischemia-reperfusion by upregulating nitric oxide synthase activity in the isolated rat hearts.
Sun HY; Xue FS; Xu YC; Li CW; Xiong J; Liao X; Zhang YM
Chin Med J (Engl); 2009 Dec; 122(24):3048-54. PubMed ID: 20137500
[TBL] [Abstract][Full Text] [Related]
22. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts.
Yasmin W; Strynadka KD; Schulz R
Cardiovasc Res; 1997 Feb; 33(2):422-32. PubMed ID: 9074708
[TBL] [Abstract][Full Text] [Related]
23. [Precondition with doxycycline administration abates ischemia/reperfusion injury and reduces the expression of matrix metalloproteinase-1/9 in myocardium in rat in vivo].
Wu LM; Fan L; Chen LL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):679-82. PubMed ID: 17996137
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury.
Krzywonos-Zawadzka A; Franczak A; Olejnik A; Radomski M; Gilmer JF; Sawicki G; Woźniak M; Bil-Lula I
J Cell Mol Med; 2019 Apr; 23(4):2836-2848. PubMed ID: 30729745
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-2 is activated during ischemia/reperfusion in a model of myocardial infarction.
Cadete VJ; Arcand SA; Chaharyn BM; Doroszko A; Sawicka J; Mousseau DD; Sawicki G
Can J Cardiol; 2013 Nov; 29(11):1495-503. PubMed ID: 23770015
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of matrix metalloproteinase 2 and 9 inhibitory action of minocycline by aspirin: an approach to attenuate outcome of acute myocardial infarction in diabetes.
Bhatt LK; Veeranjaneyulu A
Arch Med Res; 2014 Apr; 45(3):203-9. PubMed ID: 24606818
[TBL] [Abstract][Full Text] [Related]
27. Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia/reperfusion.
Gao L; Zheng YJ; Gu SS; Tan JL; Paul C; Wang YG; Yang HT
J Mol Cell Cardiol; 2014 Dec; 77():102-12. PubMed ID: 25451385
[TBL] [Abstract][Full Text] [Related]
28. Effects of simvastatin on cardiohemodynamic responses to ischemia-reperfusion in isolated rat hearts.
Zheng X; Hu SJ
Heart Vessels; 2006 Mar; 21(2):116-23. PubMed ID: 16550313
[TBL] [Abstract][Full Text] [Related]
29. Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction.
Polewicz D; Cadete VJ; Doroszko A; Hunter BE; Sawicka J; Szczesna-Cordary D; Light PE; Sawicki G
J Cell Mol Med; 2011 May; 15(5):1136-47. PubMed ID: 20518849
[TBL] [Abstract][Full Text] [Related]
30. Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury.
Falk V; Soccal PM; Grünenfelder J; Hoyt G; Walther T; Robbins RC
Eur J Cardiothorac Surg; 2002 Jul; 22(1):53-8. PubMed ID: 12103373
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.
Lalu MM; Gao CQ; Schulz R
Mol Cell Biochem; 2003 Sep; 251(1-2):61-6. PubMed ID: 14575305
[TBL] [Abstract][Full Text] [Related]
32. Activation of α1B-adrenoceptors contributes to intermittent hypobaric hypoxia-improved postischemic myocardial performance via inhibiting MMP-2 activation.
Gao L; Chen L; Lu ZZ; Gao H; Wu L; Chen YX; Zhang CM; Jiang YK; Jing Q; Zhang YY; Yang HT
Am J Physiol Heart Circ Physiol; 2014 Jun; 306(11):H1569-81. PubMed ID: 24705558
[TBL] [Abstract][Full Text] [Related]
33. Hydrogen peroxide causes cardiac dysfunction independent from its effects on matrix metalloproteinase-2 activation.
León H; Bautista-López N; Sawicka J; Schulz R
Can J Physiol Pharmacol; 2007; 85(3-4):341-8. PubMed ID: 17612643
[TBL] [Abstract][Full Text] [Related]
34. Activation of proteolytic enzymes and depression of the sarcolemmal Na+/K+-ATPase in ischemia-reperfused heart may be mediated through oxidative stress.
Singh RB; Hryshko L; Freed D; Dhalla NS
Can J Physiol Pharmacol; 2012 Feb; 90(2):249-60. PubMed ID: 22316244
[TBL] [Abstract][Full Text] [Related]
35. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits.
D'Annunzio V; Donato M; Erni L; Miksztowicz V; Buchholz B; Carrión CL; Schreier L; Wikinski R; Gelpi RJ; Berg G; Basso N
J Cardiovasc Pharmacol; 2009 Feb; 53(2):137-44. PubMed ID: 19188835
[TBL] [Abstract][Full Text] [Related]
36. Activation of proteases and changes in Na+-K+-ATPase subunits in hearts subjected to ischemia-reperfusion.
Müller AL; Freed D; Dhalla NS
J Appl Physiol (1985); 2013 Feb; 114(3):351-60. PubMed ID: 23221958
[TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
38. Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9.
Romanic AM; Harrison SM; Bao W; Burns-Kurtis CL; Pickering S; Gu J; Grau E; Mao J; Sathe GM; Ohlstein EH; Yue TL
Cardiovasc Res; 2002 Jun; 54(3):549-58. PubMed ID: 12031700
[TBL] [Abstract][Full Text] [Related]
39. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
[TBL] [Abstract][Full Text] [Related]
40. Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4.
Takawale A; Fan D; Basu R; Shen M; Parajuli N; Wang W; Wang X; Oudit GY; Kassiri Z
Circ Heart Fail; 2014 Jul; 7(4):652-62. PubMed ID: 24842912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
